Merck, Eisai discontinue late-stage study for liver cancer therapy

reuters.com/business/healthcare-pharmaceuticals/merck-eisai-discontinue-late-stage-study-liver-cancer-therapy-2025-10-29

This story appeared on reuters.com, 2025-10-29 12:00:56.671000.
The Entire Business World on a Single Page. Free to Use →